Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Deliver oxliplatin and 5-FU via HAI to breast cancer patients with liver-only or
liver-predominant metastases who have failed at least one line of systemic chemotherapy in
metastatic setting.